FOXO-regulated transcription restricts overgrowth of Tsc mutant organs

Kieran F Harvey1, Jaakko Mattila, Avi Sofer

  • 1Cell Growth and Proliferation Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. kieran.harvey@petermac.org

The Journal of Cell Biology
|February 27, 2008
PubMed

Insights

Forkhead box O (FOXO) transcription factors suppress growth, particularly when the target of rapamycin (TOR) pathway is active. This study shows FOXO antagonizes TOR-driven growth across species, including mammals.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cellular Biology

Background:

  • The role of FOXO (Forkhead box O) transcription factors in growth regulation is debated, as FOXO mutations in Drosophila do not affect fly size.
  • A previous study indicated FOXO suppresses growth under conditions of heightened target of rapamycin (TOR) pathway activity.

Purpose of the Study:

  • To further investigate the growth-suppressive role of FOXO, particularly in relation to the TOR pathway.
  • To determine if FOXO antagonizes TOR-driven growth in a conserved manner across species.

Main Methods:

  • Utilizing Drosophila melanogaster models with mutations in tuberous sclerosis complex 1 (TSC1).
  • Analyzing FOXO levels and the expression of FOXO-regulated genes in response to TSC1 mutations.
  • Comparing transcriptional changes in Drosophila with those in mammalian cell lines.

Main Results:

  • Mutations in TSC1 led to increased FOXO levels in Drosophila.
  • Elevated FOXO levels resulted in increased expression of genes that counteract growth-promoting pathways.
  • Similar transcriptional alterations were observed in mammalian cells, indicating conserved mechanisms.

Conclusions:

  • FOXO acts as a suppressor of growth, specifically counteracting growth promoted by the TOR pathway.
  • This growth-attenuating function of FOXO is conserved in both insects and mammals, highlighting its fundamental role in metabolic and growth control.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Transgenic Organisms00:53

Transgenic Organisms

Overview